Cargando…

Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study

BACKGROUND: High-quality estimates of health care costs are required to understand the burden of illness and to inform economic models. We estimated the costs associated with hepatitis C virus (HCV) infection from the public payer perspective in Ontario, Canada. METHODS: In this population-based ret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, William W.L., Haines, Alex, Bremner, Karen E., Yao, Zhan, Calzavara, Andrew, Mitsakakis, Nicholas, Kwong, Jeffrey C., Sander, Beate, Thein, Hla-Hla, Krahn, Murray D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Joule Inc. or its licensors 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034296/ https://www.ncbi.nlm.nih.gov/pubmed/33688024 http://dx.doi.org/10.9778/cmajo.20200162

Ejemplares similares

Health status utilities and the impact of pressure ulcers in long-term care residents in Ontario
por: Thein, Hla-Hla, et al.
Publicado: (2009)

Health care costs associated with hepatitis C virus infection in First Nations populations in Ontario: a retrospective matched cohort study
por: Mendlowitz, Andrew, et al.
Publicado: (2021)

Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update
por: Erman, Aysegul, et al.
Publicado: (2019)

Phase-specific and lifetime costs of cancer care in Ontario, Canada
por: de Oliveira, Claire, et al.
Publicado: (2016)

Hepatitis C virus infection in First Nations populations in Ontario from 2006 to 2014: a population-based retrospective cohort analysis
por: Mendlowitz, Andrew, et al.
Publicado: (2021)

Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study
por: Mendlowitz, Andrew B., et al.
Publicado: (2023)

Influence of Socioeconomic Status on Survival of Hepatocellular Carcinoma in the Ontario Population; A Population-Based Study, 1990–2009
por: Jembere, Nathaniel, et al.
Publicado: (2012)

Economic Appraisal of Ontario's Universal Influenza Immunization Program: A Cost-Utility Analysis
por: Sander, Beate, et al.
Publicado: (2010)

Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort study
por: Tsui, Teresa C.O., et al.
Publicado: (2022)

Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study
por: Thein, Hla-Hla, et al.
Publicado: (2015)

Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012
por: Ramsay, Lauren C., et al.
Publicado: (2020)

Specialized multi-disciplinary heart failure clinics in Ontario, Canada: an environmental scan
por: Wijeysundera, Harindra C, et al.
Publicado: (2012)

Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors
por: Granados-García, Víctor, et al.
Publicado: (2016)

A province-by-province cost-effectiveness analysis and budget impact analysis of one-time birth cohort screening of hepatitis C virus (HCV) infection in Canada
por: Wong, William W. L., et al.
Publicado: (2023)

Health-state utilities in a prisoner population: a cross-sectional survey
por: Chong, Christopher AKY, et al.
Publicado: (2009)

The Effect of HIV-Hepatitis C Co-Infection on Bone Mineral Density and Fracture: A Meta-Analysis
por: O’Neill, Tyler J., et al.
Publicado: (2014)

Estimating the Cost of Cancer Care in British Columbia and Ontario: A Canadian Inter-Provincial Comparison
por: De Oliveira, Claire, et al.
Publicado: (2017)

Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis
por: Kwon, Jisoo A., et al.
Publicado: (2021)

Cost‐effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person‐level data in a Canadian setting
por: Thein, Hla‐Hla, et al.
Publicado: (2017)

Differential Patterns by Area-Level Social Determinants of Health in Coronavirus Disease 2019 (COVID-19)–Related Mortality and Non–COVID-19 Mortality: A Population-Based Study of 11.8 Million People in Ontario, Canada
por: Wang, Linwei, et al.
Publicado: (2022)

Cost-effectiveness of measles control during elimination in Ontario, Canada, 2015
por: Ramsay, Lauren C, et al.
Publicado: (2019)

High-cost health care users in Ontario, Canada: demographic, socio-economic, and health status characteristics
por: Rosella, Laura C, et al.
Publicado: (2014)

Prevalence, Cost, and Variation in Cost of Pediatric Hospitalizations in Ontario, Canada
por: Gill, Peter J., et al.
Publicado: (2022)

Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting
por: Thein, Hla-Hla, et al.
Publicado: (2017)

Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study
por: Thein, Hla-Hla, et al.
Publicado: (2018)

Healthcare costs and outcomes associated with laboratory-confirmed Lyme disease in Ontario, Canada: A population-based cohort study
por: Mac, Stephen, et al.
Publicado: (2023)

A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners
por: Yap, Lorraine, et al.
Publicado: (2014)

Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study
por: Thein, Hla-Hla, et al.
Publicado: (2017)

Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005–2014
por: Johnson, Karen O., et al.
Publicado: (2018)

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance
por: Nasreen, Sharifa, et al.
Publicado: (2022)

Population-based estimate of hepatitis C virus prevalence in Ontario, Canada
por: Bolotin, Shelly, et al.
Publicado: (2018)

Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada
por: Buchan, Sarah A., et al.
Publicado: (2023)

The association between obesity and outpatient visits for acute respiratory infections in Ontario, Canada
por: Campitelli, Michael A., et al.
Publicado: (2013)

Pulmonary Nontuberculous Mycobacteria–Associated Deaths, Ontario, Canada, 2001–2013
por: Marras, Theodore K., et al.
Publicado: (2017)

Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada
por: Buchan, Sarah A., et al.
Publicado: (2022)

Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study
por: Sundaram, Maria E., et al.
Publicado: (2021)

A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns
por: Pereira, Jennifer A, et al.
Publicado: (2011)

Obesity and Respiratory Hospitalizations During Influenza Seasons in Ontario, Canada: A Cohort Study
por: Kwong, Jeffrey C., et al.
Publicado: (2011)

The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysis
por: Zeitouny, Seraphine, et al.
Publicado: (2023)

Rotavirus vaccine coverage and factors associated with uptake using linked data: Ontario, Canada
por: Wilson, Sarah E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d9ehjd0j8e2t4lufdvjliohrds